Cryptococcus infection pathophysiology

Jump to navigation Jump to search

Cryptococcus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cryptococcus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cryptococcus infection pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cryptococcus infection pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cryptococcus infection pathophysiology

CDC on Cryptococcus infection pathophysiology

Cryptococcus infection pathophysiology in the news

Blogs on Cryptococcus infection pathophysiology

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Cryptococcus infection pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Pathophysiology

Pathogenesis

  • Cryptococcus neoformans enters the body through the respiratory tract.
  • Immunocompetent individuals can contain C. neoformans in the lung.[1]
  • In the case of an immunocompromised host, the yeast cells division is uncontrolled and the infection can disseminate into the brain via the hematogenous route, causing meningoencephalitis.[2]
  • Cryptococcus neoformans enters the brain parenchyma passing through the blood brain barrier via a mechanism called transcytosis which is mediated by interactions between CD44 expressed on endothelium and cryptococcal hyaluronic acids.[3]

References

  1. Kwon-Chung KJ, Sorrell TC, Dromer F, Fung E, Levitz SM (2000). "Cryptococcosis: clinical and biological aspects". Med Mycol. 38 Suppl 1: 205–13. PMID 11204147.
  2. Gottfredsson M, Perfect JR (2000). "Fungal meningitis". Semin Neurol. 20 (3): 307–22. doi:10.1055/s-2000-9394. PMID 11051295.
  3. Jong A, Wu CH, Gonzales-Gomez I, Kwon-Chung KJ, Chang YC, Tseng HK; et al. (2012). "Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection". J Biol Chem. 287 (19): 15298–306. doi:10.1074/jbc.M112.353375. PMC 3346080. PMID 22418440.